Abstract
Background: To achieve optimal resource allocation in health care, it is necessary to value competing resource uses according to the benefit derived from those uses. Skin disease makes as great an impact as other serious medical conditions when assessed by effects on health-related quality of life. Objective: To confirm the high impact of skin disease by comparing patients’ willingness to pay (WTP) to be cured or relieved from symptoms of skin and nonskin conditions. Methods: We searched the published literature on WTP to compare the impact of dermatologic conditions with the impact of other medical conditions. A total of 46 articles were identified of which 10 included information on willingness to pay for cure reported on a monthly basis. Results: WTP for skin diseases fell in the range of $125–260/month and was comparable or higher than all but one of the other identified conditions. Conclusion: Willingness to pay for relief from skin diseases is comparable to that for relief of other serious medical conditions. Skin diseases are associated with a significant adverse impact on patients’ lives.
Antécédents
En vue de parvenir à une allocation optimale des ressources médicales, il est nécessaire d’en évaluer les différents usages selon les avantages de chacun. La maladie de la peau a le même effet sur la qualité de vie que toute autre maladie grave. Objectif: Confirmer 1’impact important de la maladie de la peau en comparant la volonté de payer (VDP) des patients afin de soulager les symptômes associés aux maladies de la peau et ceux associés à d’autres maladies. Méthodes: Nous avons effectué des recherches sur les publications traitant de la VDP en vue de comparer l’impact des troubles dermatologiques avec l’impact d’autres sortes d’états pathologiques. En total, 46 articles ont été identifiés, dont 10 contiennent des données sur la volonté de payer pour une guérison sur une base mensuelle. Résultats: La VDP pour un trouble dermatologique varie entre 125 $ et 260 $ par mois, ce qui est comparable ou supérieur à toutes les autres pathologies, sauf une. Conclusion: La volonté de payer afin de soulager les conditions dermatologiques est comparable à celle la VDP pour soulager d’autres maladies graves. Les troubles de la peau peuvent avoir d’importants effets nuisibles sur la vie des patients.
References
SR Rapp SR Feldman ML Exum et al. (1999) ArticleTitlePsoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41 401–407 Occurrence Handle1:STN:280:DyaK1MzovFOmuw%3D%3D Occurrence Handle10459113
G Krueger J Koo M Lebwohl et al. (2001) ArticleTitleThe impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137 280–284 Occurrence Handle1:STN:280:DC%2BD3M7pvV2jsw%3D%3D Occurrence Handle11255325
A Wahl JH Loge I Wiklund et al. (2000) ArticleTitleThe burden of psoriasis: A study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 43 803–808 Occurrence Handle10.1067/mjd.2000.107501 Occurrence Handle1:STN:280:DC%2BD3M7pt1agsw%3D%3D Occurrence Handle11050584
P O’Neill P Kelly (1996) ArticleTitlePostal questionnaire study of disability in the community associated with psoriasis. BMJ 313 IssueID7062 919–921 Occurrence Handle1:STN:280:ByiD3s%2FhsFI%3D Occurrence Handle8876097
M Ryan DA Scott C Reeves et al. (2001) ArticleTitleEliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 5 1–186 Occurrence Handle1:STN:280:DC%2BD3M7msVWrtA%3D%3D
JA Olsen RD Smith (2001) ArticleTitleTheory versus practice: a review of ‘willingness-to-pay’ in health and health care. Health Econ 10 39–52 Occurrence Handle10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E Occurrence Handle1:STN:280:DC%2BD3M3ht1Omtg%3D%3D Occurrence Handle11180568
S Birch A Gafni B O’Brien (1999) ArticleTitleWillingness to pay and the valuation of programmes for the prevention and control of influenza. Pharmacoeconomics 16 IssueIDSuppl 1 55–61 Occurrence Handle10623377
M Johannesson (1992) ArticleTitleEconomic evaluation of lipid lowering—a feasibility test of the contingent valuation approach. Health Policy 20 309–320 Occurrence Handle1:STN:280:By2B28jpsVU%3D Occurrence Handle10118015
SD Ramsey SD Sullivan BM Psaty et al. (1997) ArticleTitleWillingness to pay for antihypertensive care: evidence from a staff-model HMO. Soc Sci Med 44 1911–1917 Occurrence Handle10.1016/S0277-9536(96)00300-0 Occurrence Handle1:STN:280:ByiA3sjltFY%3D Occurrence Handle9194252
M Johannesson PO Johansson B Kristrom et al. (1993) ArticleTitleWillingness to pay for antihypertensive therapy—further results. J Health Econ 12 95–108 Occurrence Handle10.1016/0167-6296(93)90042-D Occurrence Handle1:STN:280:ByyB1cnnvFY%3D Occurrence Handle10126492
B Kartman F Andersson M Johannesson (1996) ArticleTitleWillingness to pay for reductions in angina pectoris attacks. Med Decis Making 16 248–253 Occurrence Handle1:STN:280:BymH3MrhsFI%3D Occurrence Handle8818123
K Blumenschein M Johannesson (1998) ArticleTitleRelationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 80 189–194 Occurrence Handle1:STN:280:DyaK1c7lsFGmtQ%3D%3D Occurrence Handle9494453
L Lundberg M Johannesson M Silverdahl et al. (1999) ArticleTitleQuality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 141 1067–1075 Occurrence Handle10.1046/j.1365-2133.1999.03207.x Occurrence Handle1:STN:280:DC%2BD3c%2FnsVGquw%3D%3D Occurrence Handle10606854
RJ Motley AY Finlay (1989) ArticleTitleHow much disability is caused by acne? Clin Exp Dermatol 14 194–198 Occurrence Handle1:STN:280:By%2BD2srks1A%3D Occurrence Handle2531637
SR Eastaugh (2000) ArticleTitleWillingness to pay in treatment of bleeding disorders. Int J Technol Assess Health Care 16 706–710 Occurrence Handle10.1017/S0266462300101266 Occurrence Handle1:STN:280:DC%2BD3cvitVKqtg%3D%3D Occurrence Handle10932435
MS Thompson JL Read M Liang (1984) ArticleTitleFeasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making 4 195–215 Occurrence Handle1:STN:280:BiuB1Mvmsl0%3D Occurrence Handle6433140
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Parks, L., Balkrishnan, R., Hamel–Gariépy, L. et al. The Importance of Skin Disease as Assessed by “Willingness-To-Pay”. JCMS 7, 369–371 (2003). https://doi.org/10.1007/s10227-002-0145-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10227-002-0145-y